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Two-stage liver transplantation, involving a total hepatectomy with a temporary portocaval shunt followed by 
liver transplantation, requires intensive perioperative care, especially during the prolonged anhepatic period. 
The pathophysiology and management of this prolonged anhepatic state is not fully elucidated and the proper 
management during this period is a great challenge to clinicians in the intensive care unit and anesthesiologists. We 
report a case and management of a total hepatectomy with a temporary portocaval shunt followed by living-donor 
liver transplantation in a patient with a surgically complicated liver failure after a hepatic tumor resection. (Korean J 
Anesthesiol 2010; 59: 348-352)
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    Two-stage liver transplantation (LT), involving a total 
hepatectomy with a temporary portocaval shunt followed by 
LT, requires intensive perioperative care, especially during the 
prolonged anhepatic period. Since its first introduction by Ringe 
et al. [1] in the late 1980s, this procedure has been investigated 
and performed to stabilize the hemodynamic and metabolic 
state of patients in acute hepatic or primary graft failure 
awaiting a liver graft [2-5]. However, a prolonged anhepatic state 
is still a challenge to clinicians in the intensive care units and 
anesthesiologists because the pathophysiological changes and 
proper management of the anhepatic state are not completely 
understood [6]. The clinical status of an individual patient at the 
time of a total hepatectomy and proper care of the anhepatic 
state may affect the outcome of the patient after this two-stage 
procedure [2]. We report a case and perioperative care of a total 
hepatectomy with a temporary portocaval shunt followed by 
living-donor LT in a patient with surgically complicated liver 
failure after a hepatic tumor resection.
Case Report
    A 42-year-old woman (weight: 48.8 kg, height: 159 cm), 
who underwent an extensive tumor resection for Klatskin 
tumor, Bismuth type IV, developed acute hepatic failure in 349 www.ekja.org
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the immediate postoperative period and was listed for an 
emergency LT. 
    A preoperative laboratory and radiology evaluation before 
the tumor resection were within the normal limits except for an 
elevated liver function profile (aspartate aminotransferase 170 
U/L, alanine aminotransferase 100 U/L) due to the underlying 
Klatskin tumor. The bleeding diatheses at the intensive care 
unit (ICU) were as follows: hemoglobin and platelet count 
decreased from 10.4 g/dl and 103 × 10
3/μl to 4.8 g/dl and 60 × 
10
3/μl, respectively, within the first hour at the ICU. Prothrombin 
time (PT) expressed in the international normal range (INR), 
activated partial thrombin time (aPTT), fibrinogen, fibrin 
degradation product, D-dimer, antithrombin III activity, plas-
minogen activity, protein C activity were 2.03 (normal [nl], 
0.9-1.1), 104.5 seconds (nl, 29-42 seconds), 97 mg/dl (nl, 
180-380 mg/dl), >5 μg/ml (nl, <5 μg/ml), 3.23 μg/ml (nl, 0- 
0.5 μg/ml), 41% (nl, 83-123%), 30% (nl, 75-112%), 43% (nl, 
80-161%), respectively. Metabolic acidosis of pH <7.15 with a 
progressively deteriorating base deficit >15 mmol/L and exacer-
bating hypocalcemia <0.8 mol/L and hyperglycemia >200 
mg/dl were observed throughout the ICU stay. Continuous 
infusions of calcium gluconate at 1 mg/kg/hr and 5% albumin 
were given. Bicarbonate and insulin were given intermittently 
at the discretion of the clinician. At the ICU, exsanguinating 
bleeding of more than 1,000 ml/hr was seen through a drainage 
immediately after the tumor resection. During the 11 hour 
stay at the ICU before receiving a total hepatectomy, more 
than 25 units of packed red blood cells, 16 units of each fresh 
frozen plasma, cryoprecipitate and platelet concentrates were 
administered along with a continuous infusion of 10 µg/kg/
min dopamine, 0.35 µg/kg/min norepinephrine to maintain 
the systolic blood pressure between 50 and 80 mmHg, and the 
diastolic blood pressure between 30 and 65 mmHg. The urine 
output was maintained between 20 and 100 ml/hr during 
the ICU stay. The patient was indicated to undergo a total 
hepatectomy with a temporary portocaval shunt while awaiting 
a liver graft due to the uncontrollable bleeding and hepatic toxic 
syndrome, which was postulated to be caused by acute hepatic 
necrosis and the resultant coagulation abnormality. During the 
two hour and 40 minute surgical procedure, crystalloid 8,100 
ml, packed red blood cells eight units, fresh frozen plasma four 
units, platelet concentrates eight units and cryoprecipitate six 
units were administered to replace the estimated blood loss of 
4,500 ml. The total urine output was 330 ml.
    After the total hepatectomy and portocaval shunt, the 
pa  tient was placed at the ICU and medical care for the 
anhepatic state was provided. During the anhepatic period, 
an hourly monitoring of the arterial blood gas analysis with 
an intermittent the ionic calcium level and dieresis were the 
primary concern of the ICU management. Arterial blood gas 
analyses showed an alleviation of the metabolic acidosis from 
arterial pH <7.15 and base deficit >15 mmol/L during the 
acute liver failure status to pH 7.15-7.25 and base deficit of 10-
15 mmol/L during the anhepatic period. Metabolic acidosis 
was accompanied by slight hyperchloremia ranging 110-115 
mmol/L (nl, <108 mmol/L). However, the potassium level 
was within the normal range of 3.5-3.8 mmol/L throughout 
the ICU stay before the hepatectomy. The magnesium level 
decreased only slightly ranging 1.6-1.7 mg/dl and the sodium 
level was maintained between 144 and 146 mmol/L. Persistent 
ionic hypocalcemia <0.8 mmol/L was observed despite the 
continuous infusion of calcium gluconate supplementation 
at 1 mg/kg/hr. Other continuous supplementations including 
sodium bicarbonate, magnesium, 5% albumin, 20% mannitol 
and dextrose solution were provided as needed. There was no 
rapid correction of hyponatremia or an increase in the sodium 
level owing to the use of sodium bicarbonate in this case. There 
were no neurological deficits following the abnormal changes 
in sodium level or signs of hepatic encephalopathy, even 
though comprehensive neurological examinations were not 
feasible due to the patient’s sedated and intubated condition. 
The serum glucose level was maintained between 100 and 200 
mg/dl. A warm blanket was applied to maintain the normal 
body temperature. An inotropic support with a continuous 
infusion of 5 µg/kg/min dopamine maintained the systolic 
blood pressure between 80 and 100 mmHg and diastolic 
blood pressure between 60 and 80 mmHg. At the discretion 
of the ICU specialist, 12 units of packed red blood cells, 10 
units of fresh frozen plasma, 16 units of platelet concentrates 
and 14 units of cryoprecipitate were given over an 11-hour 
period at the ICU before the liver transplant. An elevated 
creatinine level of 1.58 mg/dl and urine out of <10 ml/hr were 
observed, but continuous renal replacement therapy (CRRT) 
was not applied. The coagulation profile during the anhepatic 
period showed a prolongation of PT (INR) around 2, aPTT 
around 100 s and fibrinogen <100 mg/dl. Cytokine or other 
toxin related laboratory analyses were not performed in this 
patient. No artificial liver support, such as molecular adsorbent 
recirculating system (MARS), was applied in this patient 
because she was not considered a suitable candidate. 
    The patient was anhepatic for 15 hours before reperfusion of 
the liver in the living donor liver transplantation. Anes  the  sia was 
induced and maintained with desflurane at an oxygen fraction 
of 0.5 under routine monitoring with elec  trocardiography, SpO2, 
radial and femoral arterial pressure, pulmonary arterial pressure 
and cardiac output. Continuous vasoactive support with 5 µg/
kg/min dopamine and 0.1-0.2 µg/kg/min norepinephrine were 
maintained. The hemodynamic profile was stable throughout 
the operation before and after reperfusion of the transplanted 
liver. During the seven hour and 40 minute LT operation, 7,500 350 www.ekja.org
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ml crystalloid, 500 ml colloid, 650 ml albumin, eight units of 
packed red blood cell, four units of fresh frozen plasma, nine 
units of cryoprecipiate and one unit of platelet apheresis were 
administered.
    Postoperative care at the ICU involved cardiovascular and 
respiratory support with a CCRT. On the ninth day after LT, the 
patient became alert and on the 16th day she was extubated 
for one week until reintubated due to pulmonary effusion 
related respiratory failure. The acute renal insufficiency with 
urine output of <5 ml/hr and creatinine level between 1.5 
and 2.0 mg/dl persisted despite the best efforts to improve 
the renal function. The patient also suffered peritonitis from 
bowel anastomosis leakage and underwent two additional 
operations for anastomosis site repair. The sustained septic 
conditions throughout the ICU stay aggravated and progressed 
to multiorgan failure. The patient died on postoperative day 65.
Discussion
    A total hepatectomy with a portocaval shunt was performed 
as a bridging procedure to a LT because the patient developed 
acute liver failure, which manifested as uncontrollable massive 
bleeding and so-called “toxic liver syndrome” immediately after 
a surgical resection of a Klatskin tumor. 
    Toxic liver syndrome is one of the major indications for this 
procedure and it is known to occur after acute or fulminant 
hepatic necrosis that is often complicated by multiorgan 
failure, such as cardiovascular shock, renal failure, pulmonary 
insufficiency and cerebral dysfunction. The multiorgan involve-
ment is caused by many factors including toxic metabolites 
released from the necrotized liver and endogenous vasoactive 
materials. The mortality of this condition is rated nearly 
100%. Therefore, the elimination of the necrotized liver was 
Fig. 1. Changes in the arterial pH, base excess and ionized calcium 
level at the baseline, during the intensive care unit (ICU) stay 
before total hepatectomy, during the anhepatic state (A), and after 
reperfusion of the liver transplant (postR). (A) Arterial pH, base 
excess and ionized calcium level at the baseline and during the initial 
ICU stay after tumor resection. (B) Arterial pH, base excess and 
ionized calcium level during the anhepatic ICU stay period after the 
total hepatectomy. (C) Arterial pH, base excess and ionized calcium 
level during the anhepatic liver transplantation procedure and after 
reperfusion. The base excess and ionized calcium level vary within 
the time period of the ICU care before the total hepatectomy and 
during the anhepatic period with a continuous infusions of sodium 
bicarbonate and calcium gluconate (not indicated in the figure). 
However, these figures delineate the persistent low BE and calcium 
level despite the continuous supplementation during the anhepatic 
period until reperfusion of the liver transplant. The numbers in the 
x-axis indicate the time in minutes.351 www.ekja.org
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justified in this concept and several clinical reports showed 
that a total hepatectomy and portocaval shunt stabilized the 
hemodynamic and metabolic state, and improved the portal 
venous drainage and decompression. Our patient also became 
hemodynamically stable with fewer requirements of blood 
transfusion and inotropic support, and metabolic acidosis 
progression was slowed. Her arterial blood gas analysis with 
the ionic calcium level improved after the total hepatectomy 
and portocaval shunt (Fig. 1). Our patient did not develop liver 
failure-related neurological dysfunction during the ICU stay and 
monitoring of the ICP was not required. However patients with 
acute or fulminant liver failure, especially in cases of acute-on-
chronic liver diseases, should be considered for ICP monitoring 
[7,8]. Monitoring of ICP is not without complications, such 
as intracranial hemorrhage and infection [9]. However, since 
an elevated ICP is one of the major cases of mortality before a 
liver transplant, its beneficial role in managing ICP should be 
weighed against its complications. Although the consequences 
of a prolonged anhepatic state are not fully established, 
adequate management during the anhepatic period is essential 
to the survival until a graft is ready. Previous reports stated that 
patients in an anhepatic state rapidly develop hypoglycemia, 
hypothermia, oliguria, renal failure and hypocalcemia [6,10].
    Anhepatic patients develop hypoglycemia because the liver 
is the main source of glycogen storage, therefore needs to be 
replaced with an intravenous glucose infusion. Hypothermia 
needs to be managed with a warm blanket and the body tem-
pera  ture needs to be maintained. Oliguria and renal failure 
often develop rapidly within 24 hours of an anhepatic state, 
and early renal dysfunction might indicate a poor prognosis. 
Renal insufficiency is reported to be related to the prevalence 
of postoperative sepsis. Supports to provide renal perfusion 
by diuretics, mannitol or renal dose dopamine infusion may 
be considered [8]. Some clinicians run CCRT and some even 
prefer to apply it prophylactically. Our patient also became 
rapidly oliguric but CCRT was not applied. Ionic hypocalcemia 
is severe in prolonged anhepatic periods because citrate from 
the blood product accumulates without being metabolized 
due to the absence of liver [11]. Our patient also showed 
persistent hypocalcemia despite the continuous infusion of 
calcium supplements throughout the anhepatic period (Fig. 1). 
Vigorous calcium replacement is recommended because 
severe hypocalcemia can result in negative cardiac output and 
hemodynamic compromise. Coagulation defects in anhepatic 
patients are not as severe as indicated by the conventional 
laboratory results, and may be treated with fresh frozen plasma 
and fibrinogen [8]. Anhepatic patients also need to be cautioned 
regarding sepsis and multiorgan failure as these are reportedly 
the main cause of mortality. Although our patient also suffered 
and died of sepsis and multiorgan failure, her septic condition 
was confounded by peritonitis that was complicated from 
bowel anastomosis leakage. It is unclear if the complicated 
peritonitis persisted because of the patient’s immune downfall. 
The transplanted liver was considered to be in good function as 
the patient recovered consciousness on the ninth postoperative 
day without any signs of graft rejection. Therefore, the patient 
would have survived the liver transplant and lived had it not 
been for the complicated bowel anastomosis leakage. 
    The safety margin of time for a prolonged anhepatic state is 
also not known. The maximum duration of 41 hours, 60 hours 
and a range of 6.58 to 72.5 hours were reported by Ringe et 
al. [2], Bentdal et al. [4], and Oldhafer et al. [12] respectively. 
In this patient, the anhepatic time was 15 hours. The survival 
rate varied from study to study, but was >60% overall [10]. 
The permissible anhepatic time for a better prognosis or its 
correlation with a deterioration of the patient’s condition are 
difficult to define because the survival varies according to the 
clinical status of the patient at the time of the total hepatectomy 
and the effectiveness of supportive care before and after the 
two-stage procedure [2]. The best prognosis appears to depend 
mostly on the patient’s factors and prompt availability of a 
liver graft. In this regard, a living donor liver transplant may be 
advocated even in an emergent situation because a cadaveric 
donor may not be available in a timely manner. 
    Along with this two-stage procedure, there have been other 
efforts, such as the use of liver support devices, to sustain the 
acute or fulminant liver failure patients until a liver graft is 
ready [13,14]. Bioartificial liver support using charcoal columns 
and extracorporeal devices filled with the liver tissue has been 
reported [13], and more recently the MARS has been introduced 
as a nonbiological liver support device [14,15]. The application 
of these devices is a relatively common clinical practice because 
they remove toxic materials from the patients’ plasma, thus 
providing the patients with more time to wait for a liver graft 
by improving the hemodynamic profiles and alleviating the 
increased intracranial pressure. The MARS was not applied in 
this patient after the extensive hepatic tumor resection because 
she suffered from acute liver failure not confounded by chronic 
liver diseases and was not considered a suitable candidate. 
Her medical condition did not progress to develop hepatic 
encephalopathy or other extensive toxic status that would 
necessitate the application of the MARS during the anhepatic 
period.
    Different anesthetic demands and management schemes 
are needed for the LT in a two stage procedure compared 
to LT in general. In the two stage procedure, LT is not prone 
to develop massive bleeding as is the case in a routine LT 
procedure becuase hepatectomy and a portocaval shunt 
have already been performed. In addition, the hemodynamic 
instability originating from clamping of the portal vein does 352 www.ekja.org
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not occur during LT in the two stage procedure. Patient care 
at the ICU during the anhepatic period and anesthetic patient 
management at the beginning of the LT surgical procedure may 
share a uniform rationale regarding the ongoing prolonged 
status of the anhepatic stage even from the start of the operation 
compared to a routine LT. An evaluation of the calcium level 
and its replacement are needed more frequently at the ICU 
because hypocalcemia is particularly severe in these transplant 
recipients. 
    In conclusion, a total hepatectomy and temporary portocaval 
shunt may be performed successfully as a bridging procedure 
to liver transplantation if backed up with an adequate manage-
ment during the anhepatic period.   
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